trending Market Intelligence /marketintelligence/en/news-insights/trending/yizrbbcasbhswieyxzodug2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

VistaGen Therapeutics raises $2.3M from private placement


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

VistaGen Therapeutics raises $2.3M from private placement

VistaGen Therapeutics Inc. raised about $2.3 million from its private placement to individual investors.

The California-based company sold about 1.8 million units for $1.25 apiece.

Each unit consisted of one unregistered common share and a warrant to buy 1 unregistered common stock for $1.50 per share.

The company intends to use the proceeds for general working capital purposes.

VistaGen develops and commercializes medicines for depression and other central nervous system disorders.